SCHEMBL3342237

SCHEMBL3342237

Cc1nccc(-c2ccc(C)c(N)c2)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.53
ALDH1A1 P00352 2/20 0.53
POLB P06746 1/20 0.53
LMNA P02545 1/20 0.49
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
KMO O15229 4/20 0.42
AAK1 Q2M2I8 5/20 0.42
CYP11B1 P15538 1/20 0.42
KATNA1 O75449 1/20 0.41
MAPT P10636 1/20 0.41
PKM P14618 1/20 0.41
HPGD P15428 1/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
AURKA O14965 1/20 0.40
TTK P33981 1/20 0.40
AURKB Q96GD4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18985864 0.88 KDM4E (0.54) KDM4EALDH1A1POLBLMNAKMO
SCHEMBL1965714 0.84 KDM4E (0.57) KDM4EALDH1A1POLBLMNANPC1
SCHEMBL9107202 0.81 NPC1 (0.41) KDM4EALDH1A1POLBNPC1RAB9A
SCHEMBL14742044 0.79 KMO (0.64) KDM4EALDH1A1POLBLMNAKMO
SCHEMBL9106834 0.79 KMO (0.40) KDM4EALDH1A1NPC1RAB9AKMO
SCHEMBL21537437 0.78 KDM4E (0.59) KDM4EALDH1A1POLBLMNANPC1
SCHEMBL7236570 0.77 CCR1 (0.55) KDM4EALDH1A1LMNANPC1RAB9A
SCHEMBL10999252 0.76 AURKB (0.69) KDM4EALDH1A1POLBLMNAAAK1
SCHEMBL20732744 0.76 KDM4E (0.47) KDM4EALDH1A1POLBLMNAKMO
SCHEMBL3342234 0.76 KMO (0.47) KDM4EALDH1A1POLBLMNAKMO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 KDM4E 2591/4885ALDH1A1 1506/4885POLB 4104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.